Governments Impair EU5 Pharmaceutical Markets

BMI View: The drug markets of the EU5 countries, Germany, the UK, France, Spain and Italy, will experience a decline over the 2011-2016 forecast period. Our bearish outlook takes into account the challenging state of their economies, the governments' austerity measures and the heavy focus on cost containment in the pharmaceutical industry, as well as the impact of the patent cliff and the increasing availability of low-value, off-patented medicines (including the price pressure enforced on generic

To read the full article, please choose one of the following options: